Global Macular Degeneration Drug Pipeline Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Macular Degeneration Drug Pipeline Market Size 2017-2028

2.1.2 Macular Degeneration Drug Pipeline Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Macular Degeneration Drug Pipeline Segment by Type

2.2.1 Gene therapy

2.2.2 Small molecules

2.2.3 Stem cell therapy

2.2.4 Gene therapies

2.3 Macular Degeneration Drug Pipeline Market Size by Type

2.3.1 Macular Degeneration Drug Pipeline Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Macular Degeneration Drug Pipeline Market Size Market Share by Type (2017-2022)

2.4 Macular Degeneration Drug Pipeline Segment by Application

2.4.1 Hospital

2.4.2 Research Institute

2.4.3 Commercial

2.4.4 Other

2.5 Macular Degeneration Drug Pipeline Market Size by Application

2.5.1 Macular Degeneration Drug Pipeline Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Macular Degeneration Drug Pipeline Market Size Market Share by Application (2017-2022)

3 Macular Degeneration Drug Pipeline Market Size by Player

3.1 Macular Degeneration Drug Pipeline Market Size Market Share by Players

3.1.1 Global Macular Degeneration Drug Pipeline Revenue by Players (2020-2022)

3.1.2 Global Macular Degeneration Drug Pipeline Revenue Market Share by Players (2020-2022)

3.2 Global Macular Degeneration Drug Pipeline Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Macular Degeneration Drug Pipeline by Regions

4.1 Macular Degeneration Drug Pipeline Market Size by Regions (2017-2022)

4.2 Americas Macular Degeneration Drug Pipeline Market Size Growth (2017-2022)

4.3 APAC Macular Degeneration Drug Pipeline Market Size Growth (2017-2022)

4.4 Europe Macular Degeneration Drug Pipeline Market Size Growth (2017-2022)

4.5 Middle East & Africa Macular Degeneration Drug Pipeline Market Size Growth (2017-2022)

5 Americas

5.1 Americas Macular Degeneration Drug Pipeline Market Size by Country (2017-2022)

5.2 Americas Macular Degeneration Drug Pipeline Market Size by Type (2017-2022)

5.3 Americas Macular Degeneration Drug Pipeline Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Macular Degeneration Drug Pipeline Market Size by Region (2017-2022)

6.2 APAC Macular Degeneration Drug Pipeline Market Size by Type (2017-2022)

6.3 APAC Macular Degeneration Drug Pipeline Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Macular Degeneration Drug Pipeline by Country (2017-2022)

7.2 Europe Macular Degeneration Drug Pipeline Market Size by Type (2017-2022)

7.3 Europe Macular Degeneration Drug Pipeline Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Macular Degeneration Drug Pipeline by Region (2017-2022)

8.2 Middle East & Africa Macular Degeneration Drug Pipeline Market Size by Type (2017-2022)

8.3 Middle East & Africa Macular Degeneration Drug Pipeline Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Macular Degeneration Drug Pipeline Market Forecast

10.1 Global Macular Degeneration Drug Pipeline Forecast by Regions (2023-2028)

10.1.1 Global Macular Degeneration Drug Pipeline Forecast by Regions (2023-2028)

10.1.2 Americas Macular Degeneration Drug Pipeline Forecast

10.1.3 APAC Macular Degeneration Drug Pipeline Forecast

10.1.4 Europe Macular Degeneration Drug Pipeline Forecast

10.1.5 Middle East & Africa Macular Degeneration Drug Pipeline Forecast

10.2 Americas Macular Degeneration Drug Pipeline Forecast by Country (2023-2028)

10.2.1 United States Macular Degeneration Drug Pipeline Market Forecast

10.2.2 Canada Macular Degeneration Drug Pipeline Market Forecast

10.2.3 Mexico Macular Degeneration Drug Pipeline Market Forecast

10.2.4 Brazil Macular Degeneration Drug Pipeline Market Forecast

10.3 APAC Macular Degeneration Drug Pipeline Forecast by Region (2023-2028)

10.3.1 China Macular Degeneration Drug Pipeline Market Forecast

10.3.2 Japan Macular Degeneration Drug Pipeline Market Forecast

10.3.3 Korea Macular Degeneration Drug Pipeline Market Forecast

10.3.4 Southeast Asia Macular Degeneration Drug Pipeline Market Forecast

10.3.5 India Macular Degeneration Drug Pipeline Market Forecast

10.3.6 Australia Macular Degeneration Drug Pipeline Market Forecast

10.4 Europe Macular Degeneration Drug Pipeline Forecast by Country (2023-2028)

10.4.1 Germany Macular Degeneration Drug Pipeline Market Forecast

10.4.2 France Macular Degeneration Drug Pipeline Market Forecast

10.4.3 UK Macular Degeneration Drug Pipeline Market Forecast

10.4.4 Italy Macular Degeneration Drug Pipeline Market Forecast

10.4.5 Russia Macular Degeneration Drug Pipeline Market Forecast

10.5 Middle East & Africa Macular Degeneration Drug Pipeline Forecast by Region (2023-2028)

10.5.1 Egypt Macular Degeneration Drug Pipeline Market Forecast

10.5.2 South Africa Macular Degeneration Drug Pipeline Market Forecast

10.5.3 Israel Macular Degeneration Drug Pipeline Market Forecast

10.5.4 Turkey Macular Degeneration Drug Pipeline Market Forecast

10.5.5 GCC Countries Macular Degeneration Drug Pipeline Market Forecast

10.6 Global Macular Degeneration Drug Pipeline Forecast by Type (2023-2028)

10.7 Global Macular Degeneration Drug Pipeline Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Amgen

11.1.1 Amgen Company Information

11.1.2 Amgen Macular Degeneration Drug Pipeline Product Offered

11.1.3 Amgen Macular Degeneration Drug Pipeline Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Amgen Main Business Overview

11.1.5 Amgen Latest Developments

11.2 Roche

11.2.1 Roche Company Information

11.2.2 Roche Macular Degeneration Drug Pipeline Product Offered

11.2.3 Roche Macular Degeneration Drug Pipeline Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Roche Main Business Overview

11.2.5 Roche Latest Developments

11.3 Adverum Biotechnologies

11.3.1 Adverum Biotechnologies Company Information

11.3.2 Adverum Biotechnologies Macular Degeneration Drug Pipeline Product Offered

11.3.3 Adverum Biotechnologies Macular Degeneration Drug Pipeline Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Adverum Biotechnologies Main Business Overview

11.3.5 Adverum Biotechnologies Latest Developments

11.4 AsclepiX Therapeutics

11.4.1 AsclepiX Therapeutics Company Information

11.4.2 AsclepiX Therapeutics Macular Degeneration Drug Pipeline Product Offered

11.4.3 AsclepiX Therapeutics Macular Degeneration Drug Pipeline Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 AsclepiX Therapeutics Main Business Overview

11.4.5 AsclepiX Therapeutics Latest Developments

11.5 Bioeq AG

11.5.1 Bioeq AG Company Information

11.5.2 Bioeq AG Macular Degeneration Drug Pipeline Product Offered

11.5.3 Bioeq AG Macular Degeneration Drug Pipeline Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Bioeq AG Main Business Overview

11.5.5 Bioeq AG Latest Developments

11.6 Sinocelltech

11.6.1 Sinocelltech Company Information

11.6.2 Sinocelltech Macular Degeneration Drug Pipeline Product Offered

11.6.3 Sinocelltech Macular Degeneration Drug Pipeline Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Sinocelltech Main Business Overview

11.6.5 Sinocelltech Latest Developments

11.7 RemeGen

11.7.1 RemeGen Company Information

11.7.2 RemeGen Macular Degeneration Drug Pipeline Product Offered

11.7.3 RemeGen Macular Degeneration Drug Pipeline Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 RemeGen Main Business Overview

11.7.5 RemeGen Latest Developments

11.8 Grifols, S.A.

11.8.1 Grifols, S.A. Company Information

11.8.2 Grifols, S.A. Macular Degeneration Drug Pipeline Product Offered

11.8.3 Grifols, S.A. Macular Degeneration Drug Pipeline Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Grifols, S.A. Main Business Overview

11.8.5 Grifols, S.A. Latest Developments

11.9 Kyowa Kirin

11.9.1 Kyowa Kirin Company Information

11.9.2 Kyowa Kirin Macular Degeneration Drug Pipeline Product Offered

11.9.3 Kyowa Kirin Macular Degeneration Drug Pipeline Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Kyowa Kirin Main Business Overview

11.9.5 Kyowa Kirin Latest Developments

11.10 EyePoint Pharmaceutical

11.10.1 EyePoint Pharmaceutical Company Information

11.10.2 EyePoint Pharmaceutical Macular Degeneration Drug Pipeline Product Offered

11.10.3 EyePoint Pharmaceutical Macular Degeneration Drug Pipeline Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 EyePoint Pharmaceutical Main Business Overview

11.10.5 EyePoint Pharmaceutical Latest Developments

11.11 IVERIC Bio

11.11.1 IVERIC Bio Company Information

11.11.2 IVERIC Bio Macular Degeneration Drug Pipeline Product Offered

11.11.3 IVERIC Bio Macular Degeneration Drug Pipeline Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 IVERIC Bio Main Business Overview

11.11.5 IVERIC Bio Latest Developments

11.12 Kodiak Sciences

11.12.1 Kodiak Sciences Company Information

11.12.2 Kodiak Sciences Macular Degeneration Drug Pipeline Product Offered

11.12.3 Kodiak Sciences Macular Degeneration Drug Pipeline Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Kodiak Sciences Main Business Overview

11.12.5 Kodiak Sciences Latest Developments

11.13 Ribomic

11.13.1 Ribomic Company Information

11.13.2 Ribomic Macular Degeneration Drug Pipeline Product Offered

11.13.3 Ribomic Macular Degeneration Drug Pipeline Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Ribomic Main Business Overview

11.13.5 Ribomic Latest Developments

11.14 Lineage Cell Therapeutics

11.14.1 Lineage Cell Therapeutics Company Information

11.14.2 Lineage Cell Therapeutics Macular Degeneration Drug Pipeline Product Offered

11.14.3 Lineage Cell Therapeutics Macular Degeneration Drug Pipeline Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Lineage Cell Therapeutics Main Business Overview

11.14.5 Lineage Cell Therapeutics Latest Developments

11.15 Graybug Vision

11.15.1 Graybug Vision Company Information

11.15.2 Graybug Vision Macular Degeneration Drug Pipeline Product Offered

11.15.3 Graybug Vision Macular Degeneration Drug Pipeline Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Graybug Vision Main Business Overview

11.15.5 Graybug Vision Latest Developments

11.16 CHABiotech

11.16.1 CHABiotech Company Information

11.16.2 CHABiotech Macular Degeneration Drug Pipeline Product Offered

11.16.3 CHABiotech Macular Degeneration Drug Pipeline Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 CHABiotech Main Business Overview

11.16.5 CHABiotech Latest Developments

11.17 Shanghai Henlius Biotech

11.17.1 Shanghai Henlius Biotech Company Information

11.17.2 Shanghai Henlius Biotech Macular Degeneration Drug Pipeline Product Offered

11.17.3 Shanghai Henlius Biotech Macular Degeneration Drug Pipeline Revenue, Gross Margin and Market Share (2020-2022)

11.17.4 Shanghai Henlius Biotech Main Business Overview

11.17.5 Shanghai Henlius Biotech Latest Developments

11.18 Bio-Thera Solutions

11.18.1 Bio-Thera Solutions Company Information

11.18.2 Bio-Thera Solutions Macular Degeneration Drug Pipeline Product Offered

11.18.3 Bio-Thera Solutions Macular Degeneration Drug Pipeline Revenue, Gross Margin and Market Share (2020-2022)

11.18.4 Bio-Thera Solutions Main Business Overview

11.18.5 Bio-Thera Solutions Latest Developments

11.19 Alteogen

11.19.1 Alteogen Company Information

11.19.2 Alteogen Macular Degeneration Drug Pipeline Product Offered

11.19.3 Alteogen Macular Degeneration Drug Pipeline Revenue, Gross Margin and Market Share (2020-2022)

11.19.4 Alteogen Main Business Overview

11.19.5 Alteogen Latest Developments

11.20 Outlook Therapeutics

11.20.1 Outlook Therapeutics Company Information

11.20.2 Outlook Therapeutics Macular Degeneration Drug Pipeline Product Offered

11.20.3 Outlook Therapeutics Macular Degeneration Drug Pipeline Revenue, Gross Margin and Market Share (2020-2022)

11.20.4 Outlook Therapeutics Main Business Overview

11.20.5 Outlook Therapeutics Latest Developments

12 Research Findings and Conclusion

Table 1. Macular Degeneration Drug Pipeline Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Gene therapy

Table 3. Major Players of Small molecules

Table 4. Major Players of Stem cell therapy

Table 5. Major Players of Gene therapies

Table 6. Macular Degeneration Drug Pipeline Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 7. Global Macular Degeneration Drug Pipeline Market Size by Type (2017-2022) & ($ Millions)

Table 8. Global Macular Degeneration Drug Pipeline Market Size Market Share by Type (2017-2022)

Table 9. Macular Degeneration Drug Pipeline Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 10. Global Macular Degeneration Drug Pipeline Market Size by Application (2017-2022) & ($ Millions)

Table 11. Global Macular Degeneration Drug Pipeline Market Size Market Share by Application (2017-2022)

Table 12. Global Macular Degeneration Drug Pipeline Revenue by Players (2020-2022) & ($ Millions)

Table 13. Global Macular Degeneration Drug Pipeline Revenue Market Share by Player (2020-2022)

Table 14. Macular Degeneration Drug Pipeline Key Players Head office and Products Offered

Table 15. Macular Degeneration Drug Pipeline Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 16. New Products and Potential Entrants

Table 17. Mergers & Acquisitions, Expansion

Table 18. Global Macular Degeneration Drug Pipeline Market Size by Regions 2017-2022 & ($ Millions)

Table 19. Global Macular Degeneration Drug Pipeline Market Size Market Share by Regions (2017-2022)

Table 20. Americas Macular Degeneration Drug Pipeline Market Size by Country (2017-2022) & ($ Millions)

Table 21. Americas Macular Degeneration Drug Pipeline Market Size Market Share by Country (2017-2022)

Table 22. Americas Macular Degeneration Drug Pipeline Market Size by Type (2017-2022) & ($ Millions)

Table 23. Americas Macular Degeneration Drug Pipeline Market Size Market Share by Type (2017-2022)

Table 24. Americas Macular Degeneration Drug Pipeline Market Size by Application (2017-2022) & ($ Millions)

Table 25. Americas Macular Degeneration Drug Pipeline Market Size Market Share by Application (2017-2022)

Table 26. APAC Macular Degeneration Drug Pipeline Market Size by Region (2017-2022) & ($ Millions)

Table 27. APAC Macular Degeneration Drug Pipeline Market Size Market Share by Region (2017-2022)

Table 28. APAC Macular Degeneration Drug Pipeline Market Size by Type (2017-2022) & ($ Millions)

Table 29. APAC Macular Degeneration Drug Pipeline Market Size Market Share by Type (2017-2022)

Table 30. APAC Macular Degeneration Drug Pipeline Market Size by Application (2017-2022) & ($ Millions)

Table 31. APAC Macular Degeneration Drug Pipeline Market Size Market Share by Application (2017-2022)

Table 32. Europe Macular Degeneration Drug Pipeline Market Size by Country (2017-2022) & ($ Millions)

Table 33. Europe Macular Degeneration Drug Pipeline Market Size Market Share by Country (2017-2022)

Table 34. Europe Macular Degeneration Drug Pipeline Market Size by Type (2017-2022) & ($ Millions)

Table 35. Europe Macular Degeneration Drug Pipeline Market Size Market Share by Type (2017-2022)

Table 36. Europe Macular Degeneration Drug Pipeline Market Size by Application (2017-2022) & ($ Millions)

Table 37. Europe Macular Degeneration Drug Pipeline Market Size Market Share by Application (2017-2022)

Table 38. Middle East & Africa Macular Degeneration Drug Pipeline Market Size by Region (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Macular Degeneration Drug Pipeline Market Size Market Share by Region (2017-2022)

Table 40. Middle East & Africa Macular Degeneration Drug Pipeline Market Size by Type (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Macular Degeneration Drug Pipeline Market Size Market Share by Type (2017-2022)

Table 42. Middle East & Africa Macular Degeneration Drug Pipeline Market Size by Application (2017-2022) & ($ Millions)

Table 43. Middle East & Africa Macular Degeneration Drug Pipeline Market Size Market Share by Application (2017-2022)

Table 44. Key Market Drivers & Growth Opportunities of Macular Degeneration Drug Pipeline

Table 45. Key Market Challenges & Risks of Macular Degeneration Drug Pipeline

Table 46. Key Industry Trends of Macular Degeneration Drug Pipeline

Table 47. Global Macular Degeneration Drug Pipeline Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 48. Global Macular Degeneration Drug Pipeline Market Size Market Share Forecast by Regions (2023-2028)

Table 49. Global Macular Degeneration Drug Pipeline Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 50. Global Macular Degeneration Drug Pipeline Market Size Market Share Forecast by Type (2023-2028)

Table 51. Global Macular Degeneration Drug Pipeline Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 52. Global Macular Degeneration Drug Pipeline Market Size Market Share Forecast by Application (2023-2028)

Table 53. Amgen Details, Company Type, Macular Degeneration Drug Pipeline Area Served and Its Competitors

Table 54. Amgen Macular Degeneration Drug Pipeline Product Offered

Table 55. Amgen Macular Degeneration Drug Pipeline Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 56. Amgen Main Business

Table 57. Amgen Latest Developments

Table 58. Roche Details, Company Type, Macular Degeneration Drug Pipeline Area Served and Its Competitors

Table 59. Roche Macular Degeneration Drug Pipeline Product Offered

Table 60. Roche Main Business

Table 61. Roche Macular Degeneration Drug Pipeline Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 62. Roche Latest Developments

Table 63. Adverum Biotechnologies Details, Company Type, Macular Degeneration Drug Pipeline Area Served and Its Competitors

Table 64. Adverum Biotechnologies Macular Degeneration Drug Pipeline Product Offered

Table 65. Adverum Biotechnologies Main Business

Table 66. Adverum Biotechnologies Macular Degeneration Drug Pipeline Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 67. Adverum Biotechnologies Latest Developments

Table 68. AsclepiX Therapeutics Details, Company Type, Macular Degeneration Drug Pipeline Area Served and Its Competitors

Table 69. AsclepiX Therapeutics Macular Degeneration Drug Pipeline Product Offered

Table 70. AsclepiX Therapeutics Main Business

Table 71. AsclepiX Therapeutics Macular Degeneration Drug Pipeline Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 72. AsclepiX Therapeutics Latest Developments

Table 73. Bioeq AG Details, Company Type, Macular Degeneration Drug Pipeline Area Served and Its Competitors

Table 74. Bioeq AG Macular Degeneration Drug Pipeline Product Offered

Table 75. Bioeq AG Main Business

Table 76. Bioeq AG Macular Degeneration Drug Pipeline Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 77. Bioeq AG Latest Developments

Table 78. Sinocelltech Details, Company Type, Macular Degeneration Drug Pipeline Area Served and Its Competitors

Table 79. Sinocelltech Macular Degeneration Drug Pipeline Product Offered

Table 80. Sinocelltech Main Business

Table 81. Sinocelltech Macular Degeneration Drug Pipeline Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 82. Sinocelltech Latest Developments

Table 83. RemeGen Details, Company Type, Macular Degeneration Drug Pipeline Area Served and Its Competitors

Table 84. RemeGen Macular Degeneration Drug Pipeline Product Offered

Table 85. RemeGen Main Business

Table 86. RemeGen Macular Degeneration Drug Pipeline Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 87. RemeGen Latest Developments

Table 88. Grifols, S.A. Details, Company Type, Macular Degeneration Drug Pipeline Area Served and Its Competitors

Table 89. Grifols, S.A. Macular Degeneration Drug Pipeline Product Offered

Table 90. Grifols, S.A. Main Business

Table 91. Grifols, S.A. Macular Degeneration Drug Pipeline Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 92. Grifols, S.A. Latest Developments

Table 93. Kyowa Kirin Details, Company Type, Macular Degeneration Drug Pipeline Area Served and Its Competitors

Table 94. Kyowa Kirin Macular Degeneration Drug Pipeline Product Offered

Table 95. Kyowa Kirin Main Business

Table 96. Kyowa Kirin Macular Degeneration Drug Pipeline Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 97. Kyowa Kirin Latest Developments

Table 98. EyePoint Pharmaceutical Details, Company Type, Macular Degeneration Drug Pipeline Area Served and Its Competitors

Table 99. EyePoint Pharmaceutical Macular Degeneration Drug Pipeline Product Offered

Table 100. EyePoint Pharmaceutical Main Business

Table 101. EyePoint Pharmaceutical Macular Degeneration Drug Pipeline Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 102. EyePoint Pharmaceutical Latest Developments

Table 103. IVERIC Bio Details, Company Type, Macular Degeneration Drug Pipeline Area Served and Its Competitors

Table 104. IVERIC Bio Macular Degeneration Drug Pipeline Product Offered

Table 105. IVERIC Bio Macular Degeneration Drug Pipeline Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 106. IVERIC Bio Main Business

Table 107. IVERIC Bio Latest Developments

Table 108. Kodiak Sciences Details, Company Type, Macular Degeneration Drug Pipeline Area Served and Its Competitors

Table 109. Kodiak Sciences Macular Degeneration Drug Pipeline Product Offered

Table 110. Kodiak Sciences Main Business

Table 111. Kodiak Sciences Macular Degeneration Drug Pipeline Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 112. Kodiak Sciences Latest Developments

Table 113. Ribomic Details, Company Type, Macular Degeneration Drug Pipeline Area Served and Its Competitors

Table 114. Ribomic Macular Degeneration Drug Pipeline Product Offered

Table 115. Ribomic Main Business

Table 116. Ribomic Macular Degeneration Drug Pipeline Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 117. Ribomic Latest Developments

Table 118. Lineage Cell Therapeutics Details, Company Type, Macular Degeneration Drug Pipeline Area Served and Its Competitors

Table 119. Lineage Cell Therapeutics Macular Degeneration Drug Pipeline Product Offered

Table 120. Lineage Cell Therapeutics Main Business

Table 121. Lineage Cell Therapeutics Macular Degeneration Drug Pipeline Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 122. Lineage Cell Therapeutics Latest Developments

Table 123. Graybug Vision Details, Company Type, Macular Degeneration Drug Pipeline Area Served and Its Competitors

Table 124. Graybug Vision Macular Degeneration Drug Pipeline Product Offered

Table 125. Graybug Vision Main Business

Table 126. Graybug Vision Macular Degeneration Drug Pipeline Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 127. Graybug Vision Latest Developments

Table 128. CHABiotech Details, Company Type, Macular Degeneration Drug Pipeline Area Served and Its Competitors

Table 129. CHABiotech Macular Degeneration Drug Pipeline Product Offered

Table 130. CHABiotech Main Business

Table 131. CHABiotech Macular Degeneration Drug Pipeline Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 132. CHABiotech Latest Developments

Table 133. Shanghai Henlius Biotech Details, Company Type, Macular Degeneration Drug Pipeline Area Served and Its Competitors

Table 134. Shanghai Henlius Biotech Macular Degeneration Drug Pipeline Product Offered

Table 135. Shanghai Henlius Biotech Main Business

Table 136. Shanghai Henlius Biotech Macular Degeneration Drug Pipeline Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 137. Shanghai Henlius Biotech Latest Developments

Table 138. Bio-Thera Solutions Details, Company Type, Macular Degeneration Drug Pipeline Area Served and Its Competitors

Table 139. Bio-Thera Solutions Macular Degeneration Drug Pipeline Product Offered

Table 140. Bio-Thera Solutions Main Business

Table 141. Bio-Thera Solutions Macular Degeneration Drug Pipeline Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 142. Bio-Thera Solutions Latest Developments

Table 143. Alteogen Details, Company Type, Macular Degeneration Drug Pipeline Area Served and Its Competitors

Table 144. Alteogen Macular Degeneration Drug Pipeline Product Offered

Table 145. Alteogen Main Business

Table 146. Alteogen Macular Degeneration Drug Pipeline Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 147. Alteogen Latest Developments

Table 148. Outlook Therapeutics Details, Company Type, Macular Degeneration Drug Pipeline Area Served and Its Competitors

Table 149. Outlook Therapeutics Macular Degeneration Drug Pipeline Product Offered

Table 150. Outlook Therapeutics Main Business

Table 151. Outlook Therapeutics Macular Degeneration Drug Pipeline Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 152. Outlook Therapeutics Latest Developments

List of Figures

Figure 1. Macular Degeneration Drug Pipeline Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Macular Degeneration Drug Pipeline Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Macular Degeneration Drug Pipeline Market Size Market Share by Type in 2021

Figure 7. Macular Degeneration Drug Pipeline in Hospital

Figure 8. Global Macular Degeneration Drug Pipeline Market: Hospital (2017-2022) & ($ Millions)

Figure 9. Macular Degeneration Drug Pipeline in Research Institute

Figure 10. Global Macular Degeneration Drug Pipeline Market: Research Institute (2017-2022) & ($ Millions)

Figure 11. Macular Degeneration Drug Pipeline in Commercial

Figure 12. Global Macular Degeneration Drug Pipeline Market: Commercial (2017-2022) & ($ Millions)

Figure 13. Macular Degeneration Drug Pipeline in Other

Figure 14. Global Macular Degeneration Drug Pipeline Market: Other (2017-2022) & ($ Millions)

Figure 15. Global Macular Degeneration Drug Pipeline Market Size Market Share by Application in 2021

Figure 16. Global Macular Degeneration Drug Pipeline Revenue Market Share by Player in 2021

Figure 17. Global Macular Degeneration Drug Pipeline Market Size Market Share by Regions (2017-2022)

Figure 18. Americas Macular Degeneration Drug Pipeline Market Size 2017-2022 ($ Millions)

Figure 19. APAC Macular Degeneration Drug Pipeline Market Size 2017-2022 ($ Millions)

Figure 20. Europe Macular Degeneration Drug Pipeline Market Size 2017-2022 ($ Millions)

Figure 21. Middle East & Africa Macular Degeneration Drug Pipeline Market Size 2017-2022 ($ Millions)

Figure 22. Americas Macular Degeneration Drug Pipeline Value Market Share by Country in 2021

Figure 23. Americas Macular Degeneration Drug Pipeline Consumption Market Share by Type in 2021

Figure 24. Americas Macular Degeneration Drug Pipeline Market Size Market Share by Application in 2021

Figure 25. United States Macular Degeneration Drug Pipeline Market Size Growth 2017-2022 ($ Millions)

Figure 26. Canada Macular Degeneration Drug Pipeline Market Size Growth 2017-2022 ($ Millions)

Figure 27. Mexico Macular Degeneration Drug Pipeline Market Size Growth 2017-2022 ($ Millions)

Figure 28. Brazil Macular Degeneration Drug Pipeline Market Size Growth 2017-2022 ($ Millions)

Figure 29. APAC Macular Degeneration Drug Pipeline Market Size Market Share by Region in 2021

Figure 30. APAC Macular Degeneration Drug Pipeline Market Size Market Share by Application in 2021

Figure 31. China Macular Degeneration Drug Pipeline Market Size Growth 2017-2022 ($ Millions)

Figure 32. Japan Macular Degeneration Drug Pipeline Market Size Growth 2017-2022 ($ Millions)

Figure 33. Korea Macular Degeneration Drug Pipeline Market Size Growth 2017-2022 ($ Millions)

Figure 34. Southeast Asia Macular Degeneration Drug Pipeline Market Size Growth 2017-2022 ($ Millions)

Figure 35. India Macular Degeneration Drug Pipeline Market Size Growth 2017-2022 ($ Millions)

Figure 36. Australia Macular Degeneration Drug Pipeline Market Size Growth 2017-2022 ($ Millions)

Figure 37. Europe Macular Degeneration Drug Pipeline Market Size Market Share by Country in 2021

Figure 38. Europe Macular Degeneration Drug Pipeline Market Size Market Share by Type in 2021

Figure 39. Europe Macular Degeneration Drug Pipeline Market Size Market Share by Application in 2021

Figure 40. Germany Macular Degeneration Drug Pipeline Market Size Growth 2017-2022 ($ Millions)

Figure 41. France Macular Degeneration Drug Pipeline Market Size Growth 2017-2022 ($ Millions)

Figure 42. UK Macular Degeneration Drug Pipeline Market Size Growth 2017-2022 ($ Millions)

Figure 43. Italy Macular Degeneration Drug Pipeline Market Size Growth 2017-2022 ($ Millions)

Figure 44. Russia Macular Degeneration Drug Pipeline Market Size Growth 2017-2022 ($ Millions)

Figure 45. Middle East & Africa Macular Degeneration Drug Pipeline Market Size Market Share by Region in 2021

Figure 46. Middle East & Africa Macular Degeneration Drug Pipeline Market Size Market Share by Type in 2021

Figure 47. Middle East & Africa Macular Degeneration Drug Pipeline Market Size Market Share by Application in 2021

Figure 48. Egypt Macular Degeneration Drug Pipeline Market Size Growth 2017-2022 ($ Millions)

Figure 49. South Africa Macular Degeneration Drug Pipeline Market Size Growth 2017-2022 ($ Millions)

Figure 50. Israel Macular Degeneration Drug Pipeline Market Size Growth 2017-2022 ($ Millions)

Figure 51. Turkey Macular Degeneration Drug Pipeline Market Size Growth 2017-2022 ($ Millions)

Figure 52. GCC Country Macular Degeneration Drug Pipeline Market Size Growth 2017-2022 ($ Millions)

Figure 53. Americas Macular Degeneration Drug Pipeline Market Size 2023-2028 ($ Millions)

Figure 54. APAC Macular Degeneration Drug Pipeline Market Size 2023-2028 ($ Millions)

Figure 55. Europe Macular Degeneration Drug Pipeline Market Size 2023-2028 ($ Millions)

Figure 56. Middle East & Africa Macular Degeneration Drug Pipeline Market Size 2023-2028 ($ Millions)

Figure 57. United States Macular Degeneration Drug Pipeline Market Size 2023-2028 ($ Millions)

Figure 58. Canada Macular Degeneration Drug Pipeline Market Size 2023-2028 ($ Millions)

Figure 59. Mexico Macular Degeneration Drug Pipeline Market Size 2023-2028 ($ Millions)

Figure 60. Brazil Macular Degeneration Drug Pipeline Market Size 2023-2028 ($ Millions)

Figure 61. China Macular Degeneration Drug Pipeline Market Size 2023-2028 ($ Millions)

Figure 62. Japan Macular Degeneration Drug Pipeline Market Size 2023-2028 ($ Millions)

Figure 63. Korea Macular Degeneration Drug Pipeline Market Size 2023-2028 ($ Millions)

Figure 64. Southeast Asia Macular Degeneration Drug Pipeline Market Size 2023-2028 ($ Millions)

Figure 65. India Macular Degeneration Drug Pipeline Market Size 2023-2028 ($ Millions)

Figure 66. Australia Macular Degeneration Drug Pipeline Market Size 2023-2028 ($ Millions)

Figure 67. Germany Macular Degeneration Drug Pipeline Market Size 2023-2028 ($ Millions)

Figure 68. France Macular Degeneration Drug Pipeline Market Size 2023-2028 ($ Millions)

Figure 69. UK Macular Degeneration Drug Pipeline Market Size 2023-2028 ($ Millions)

Figure 70. Italy Macular Degeneration Drug Pipeline Market Size 2023-2028 ($ Millions)

Figure 71. Russia Macular Degeneration Drug Pipeline Market Size 2023-2028 ($ Millions)

Figure 72. Spain Macular Degeneration Drug Pipeline Market Size 2023-2028 ($ Millions)

Figure 73. Egypt Macular Degeneration Drug Pipeline Market Size 2023-2028 ($ Millions)

Figure 74. South Africa Macular Degeneration Drug Pipeline Market Size 2023-2028 ($ Millions)

Figure 75. Israel Macular Degeneration Drug Pipeline Market Size 2023-2028 ($ Millions)

Figure 76. Turkey Macular Degeneration Drug Pipeline Market Size 2023-2028 ($ Millions)

Figure 77. GCC Countries Macular Degeneration Drug Pipeline Market Size 2023-2028 ($ Millions)